Pneumococcal vaccine recommendations are constantly evolving to respond to shifting patterns of infections, which is a good thing. However, the nuances can be complicated to explain to patients. Listen in to learn how experts Richard Colgan, MD and Brenda L. Tesini, MD, discuss changing pneumococcal vaccine recommendations. Topics covered include: Epidemiologic changes: S. pneumoniae over time Burden on patients and the health system Adjustments to pneumococcal vaccine recommendations Considerat...
Jun 05, 2026•17 min•Ep. 510
Viral hepatitis is an ongoing public health threat, despite the long-standing availability of effective vaccines for hepatitis A and B. Here, experts Paul Kwo, MD, Jewel Mullen, MD, MPH, MPA, FACP, and Su Wang, MD, MPH, FACP, discuss how to incorporate knowledge of hepatitis A and B risk factors and disease burden into patient counseling to enhance uptake of hepatitis A and B vaccines. Topics covered include: The burden of hepatitis A and B in the United States Risk factors for infection Current...
Jun 01, 2026•38 min•Ep. 509
Listen in to learn the latest on ART switch strategies for people living with virologically suppressed HIV. Hear from experts Chloe Orkin, MBChB, FRCP, MD, and Peter J. Ruane, MD, as they review how the recent approvals fit in the treatment landscape of 2-drug, single-tablet regimens. Stream on the go or follow along with our expert-curated slides . Topics covered include: Guideline recommendations on ART switch in the setting of virologic suppression Phase III clinical trial data supporting ART...
May 15, 2026•29 min•Ep. 508
Listen now as experts, Chloe Orkin, MBChB, FRCP, MD, and Jihad Slim, MD, explore the potential clinical implications of new data on novel options for optimizing HIV therapy, especially for treatment-experienced people with challenges using currently available regimens, high pill burdens, and reduced adherence. Listen on the go or follow along with our expert-curated slides . Topics covered include: Current Options for Simplifying ART DHHS and EACS Recommendations for 2-Drug Regimens The Latest R...
May 08, 2026•24 min•Ep. 507
Listen as Bright Ansah, patient advocate, describes his experience with being diagnosed with chronic hepatitis B as a recent immigrant to the United States and the unique barriers to treatment faced by the African immigrant community. Through his story, learn how healthcare professionals can reduce these barriers for this key population. Topics covered include: Key barriers to care for African immigrant patients Myths and misconceptions about HBV in the African immigrant community Get access to ...
May 07, 2026•8 min•Ep. 506
Listen as experts Charlotte-Paige Rolle, MD, MPH, and Paul E. Sax, MD, discuss the most recent studies on emerging treatment options for treatment-experienced people living with HIV. Topics covered include: ARTISTRY-1 and -2 data on the investigational combination of BIC/LEN Data on investigational DOR/ISL, specifically in people with multidrug-resistant HIV bNAb combinations SUPLA trial of LA CAB plus RPV in people with viremia who have challenges with their oral regimens To download the accomp...
Apr 22, 2026•22 min•Ep. 504
For US veterans, support for continued engagement in hepatitis B (HBV) care has been lacking. Listen in as Richelle M. Gaiter, DMSc, MPAS, Med, shares her experiences with HBV care as an Air Force veteran and what can be done to improve HBV care for veterans and civilians alike. Topics include: Key barriers to HBV care for US veterans What has improved in the last decade Strategies for improved engagement in care Get access to all of our new podcasts by subscribing to the Decera Clinical Educati...
Apr 20, 2026•7 min•Ep. 503
Unwanted body habitus changes among people living with HIV receiving antiretroviral therapy (ART) can negatively affect physical and mental health and may even affect ART adherence. Listen to learn from experts Grace A. McComsey, MD, FIDSA, and Richard A. Elion, MD, how to identify people who may be candidates for pharmacologic weight interventions, and hear firsthand from patient advocates how unwanted weight gain impacts their daily life. Topics covered include: The burden of unwanted weight g...
Apr 15, 2026•29 min•Ep. 502
In this episode, featuring audio from a local live workshop, experts Richard Colgan, MD, and Christopher Smith, MD, explore the burden of complicated urinary tract infection (cUTI) on patients and the healthcare system, highlight advances in the treatment of complicated UTIs, and examine approaches to empiric and definitive antibiotic therapy. Topics covered include: The Burden of cUTI and Antimicrobial Resistance Changes in IDSA Guidelines for cUTI Diagnosing cUTI Selection of Empiric and Defin...
Apr 10, 2026•28 min•Ep. 501
“Good enough” is no longer good enough when caring for treatment-experienced people with HIV. Tune in to find out what’s new in management of multidrug-resistant HIV and dig into the latest data from CROI 2026. Topics covered include: Real-world experiences with LEN in the United States and Europe for management of multidrug-resistant HIV Pharmacokinetic profiles of combined LA CAB + LEN Ibalizumab for multidrug-resistant HIV Long-term 7-year outcomes for heavily treatment–experienced people liv...
Mar 23, 2026•25 min•Ep. 500
Tune into this podcast, featuring audio from a live conference coverage webinar, to learn from global experts, Monica Gandhi, MD, MPH, and Jean-Michel Molina, MD, as they summarize and discuss the latest updates on HIV treatment and prevention from CROI 2026. Topics covered include: Emerging HIV treatments Advances in HIV prevention Investigational agents for HIV prevention Early-phase investigational HIV treatments For more coverage of CROI 2026, and to follow along with the downloadable slides...
Mar 13, 2026•54 min•Ep. 499
Cytomegalovirus (CMV) infection is one of the most significant infectious complications after hematopoietic cell transplant (HCT), but there have been major advances in CMV management to date. In this podcast, featuring curated audio from a live satellite symposium, experts Roy F. Chemaly, MD, MPH, FIDSA, FACP, FESCMID, and Marcus Pereira, MD, MPH, FAST, discuss considerations for CMV treatment in HCT recipients and examine treatment options for refractory/resistant CMV. Topics include: Consider...
Mar 09, 2026•25 min•Ep. 498
Cytomegalovirus (CMV) infection is one of the most significant infectious complications after hematopoietic cell transplant (HCT). In this podcast, featuring curated audio from a live satellite symposium, experts Roy F. Chemaly, MD, MPH, FIDSA, FACP, FESCMID and Marcus Pereira, MD, MPH, FAST, discuss the burden of CMV in HCT recipients and explore strategies effectively identify and monitor high-risk patients. Topics include: Epidemiology of CMV among HCT recipients Direct and indirect effects o...
Mar 09, 2026•15 min•Ep. 497
In this podcast, experts Jacinda (JAM) Abdul-Mutakabbir, PharmD, MPH; Ruth Carrico, PhD, DNP, FNP-C, FAAN; and Dalilah Restrepo, MD, discuss improving shingles vaccine uptake. Topics covered include: The Burden of Shingles Care Coordination Between Primary and Specialty Care Promoting Shingles Vaccine Series Completion Addressing Disparities in Shingles Vaccine Access and Uptake Presenters: Jacinda (JAM) Abdul-Mutakabbir, PharmD, MPH Associate Professor of Clinical Pharmacy University of Califor...
Feb 17, 2026•29 min•Ep. 496
Historically, key symptoms of primary biliary cholangitis (PBC), such as pruritus and fatigue, have been understudied and undertreated. Listen now to learn how symptom management should be considered independently of PBC management, and how new therapeutic agents can help. Topics covered include: Mechanisms of pruritus and fatigue in PBC Nonpharmacologic treatment options An overview of clinical trial data supporting second-line agents for symptom management: Bezafibrate Elafibranor Seladelpar I...
Feb 03, 2026•38 min•Ep. 494
New therapeutic agents for second-line treatment are raising the bar for primary biliary cholangitis (PBC) management. Listen now to learn how to incorporate these new agents into clinical practice and how these agents will impact attainment of treatment goals. Topics covered include: Available agents for second-line treatment of PBC An overview of clinical trial data supporting second-line agents: Obeticholic acid (OCA) Bezafibrate Elafibranor Seladelpar This episode is the second of 3 recap po...
Feb 03, 2026•17 min•Ep. 493
Advancements in our understanding of primary biliary cholangitis (PBC) and new therapeutic agents have reshaped the care landscape of PBC. Listen now to learn how these developments are helping to redefine and elevate treatment goals. Topics covered include: How and when to assess treatment response Risk factors in PBC Biochemical treatment response and fibrosis stage as predictors of transplant-free survival Dynamics of liver stiffness measurements and clinical outcomes in PBC The importance of...
Feb 03, 2026•18 min•Ep. 492
Tune in to listen as expert faculty, Dr Christopher L. Bowlus and Dr Sonal Kumar, discuss recent developments in treating primary biliary cholangitis (PBC) with new and emerging agents, as well as strategies to integrate these advances into clinical practice. Topics covered include: Methods of Assessing PBC Disease Progression Newer Agents for Second-line Treatment of PBC Prioritizing Symptom Management and Quality of Life With PBC Treatment Presenters : Christopher L. Bowlus, MD Lena Valenta Pr...
Feb 02, 2026•48 min•Ep. 491
Listen in as Nancy Reau, MD, reviews key highlights of the most impactful primary biliary cholangitis (PBC) research and gain insights on how to apply these new advances to clinical practice. Topics covered include: Treatment Goals Long-term Data With PPAR Agonists Investigational Therapies for Pruritus Presenter : Nancy Reau, MD Professor of Medicine Richard B. Capps Chair of Hepatology Chief, Section of Hepatology Associate Director, Solid Organ Transplantation Rush University Medical Center C...
Feb 02, 2026•15 min•Ep. 490
Recent advances in primary biliary cholangitis (PBC) care have resulted in a new focus on personalized care and symptom management. Tune in to learn from patient advocate, Maria G. Morais, RN, how you can integrate patient insights and priorities into treatment plans for PBC. Topics covered include: The Canadian PBC Society Survey: Comorbidities and Treatment Goals Defining and Achieving Goal-Driven Care for PBC Recent Advances in PBC Management Newer Agents for Second-line Treatment of PBC Pres...
Feb 02, 2026•13 min•Ep. 489
Listen to this podcast featuring highlights from our expert roundtable discussion to learn about the most pressing issues in pediatric influenza vaccines, including current vaccine technologies, recent vaccine uptake and epidemiologic trends, and how to discuss the vast benefits of timely vaccination in pediatric patients with their parents and caregivers. Topics covered include: Groups at High Risk for Complications Guideline Recommendations for Influenza Vaccination Available Seasonal Flu Vacc...
Jan 15, 2026•30 min•Ep. 487
Tune in as Princy N. Kumar, MD, MACP, FRCP, and Charlotte-Paige Rolle, MD, MPH discuss the latest in immune recovery, chronic inflammation, and more in the management of treatment-experienced people living with HIV. Topics covered include: Immunologic nonresponse Theories around soluble gp120 and antibody-dependent cellular cytotoxicity Latest data from BRIGHTE, RECOVER, and more Future Directions Presenters: Princy N. Kumar, MD, MACP, FRCP Professor of Medicine and Microbiology Chief, Division ...
Jan 15, 2026•28 min•Ep. 486
Tune into this podcast to revisit discussions led by global experts, Karine Lacombe, MD, PhD, and Chloe Orkin, MBChB, FRCP, MD, featuring the latest updates on HIV treatment and prevention from the 2025 IDWeek and EACS conferences. Topics covered include: Real-world safety and efficacy of long-acting ART ART switch: preferences, treatment satisfaction, changes in weight and metabolic parameters, and HBV reactivation risk Investigational therapies Updates on long-acting PrEP: persistence, use in ...
Dec 18, 2025•37 min•Ep. 485
In this podcast, featuring audio from an expert roundtable video module, listen as 3 multidisciplinary faculty, Tracey Q. Davidoff, MD, FCUCM; Carina Marquez, MD, MPH; and Jeffrey D. Whitman, MD, MS, discuss the benefits of diagnosing respiratory syncytial virus (RSV) and optimal testing strategies. Topics covered include: The annual burden of RSV and the benefits of diagnosis Whom to test and what diagnostic techniques to use Logistical considerations for implementation Potential benefits of RS...
Dec 15, 2025•1 hr 5 min•Ep. 484
Every day, I hear patients share worries shaped by the growing wave of vaccine misinformation—questions that reveal just how overwhelming today’s “infodemic” has become. In this podcast, I explore what vaccine hesitancy really looks like and how pharmacists can use empathy, strong recommendations, and meaningful dialogue to help rebuild confidence in immunization. Presenter: Mary Barna Bridgeman, PharmD, BCPS, BCGP Clinical Professor Ernest Mario School of Pharmacy Rutgers, The State University ...
Dec 12, 2025•8 min•Ep. 483
This episode focuses on hearing the voices of transgender people living with HIV and their advocates as they share what matters most to them when it comes to healthcare services and where HIV fits among those priorities. We also consider how these insights can assist healthcare professionals in configuring HIV care to better meet the needs of this key population. Topics addressed include: Overarching health and well-being priorities within the broader context of everyday life challenges Personal...
Dec 04, 2025•34 min•Ep. 482
Molecular point-of-care testing has the potential to substantially mitigate the impact of sexually transmitted infections (STIs) on personal and public health. Listen in to learn how it may even limit the development of antimicrobial resistance. Topics covered include: CDC and US Preventive Services Task Force STI screening recommendations Whether or not laboratory-based STI tests contribute to increasing antibiotic resistance Role of point-of-care testing and strategies for implementation Prese...
Dec 02, 2025•11 min•Ep. 481
The crux of HIV care and prevention is quick and accurate diagnosis. Listen in to learn from Aniruddha (Anu) Hazra, MD, and Dr. Nancy S. Miller about the advantages and potential pitfalls of different HIV testing algorithms to find out which one is best suited for your practice. Presenters: Aniruddha (Anu) Hazra, MD Associate Professor, Section of Infectious Diseases and Global Health Medical Director, UCM Sexual Wellness Clinic Director of STI Services, Chicago Center of HIV Elimination Departm...
Dec 02, 2025•17 min•Ep. 476
Listen in as experts Thomas P. Lodise, PharmD, PhD, and George Sakoulas, MD, FIDSA, explore tailored antibiotic strategies for diverse patients with acute bacterial skin and skin structure infections (ABSSSIs). Their insightful discussion focuses on antibiotic developments that followed publication of the IDSA practice guidelines in 2014 and the challenges unique to ABSSSIs, including a lack of determined bacterial etiology for many cases. Presenters Thomas P. Lodise, PharmD, PhD Professor Alban...
Nov 26, 2025•46 min•Ep. 472
Look beyond viral suppression to learn how people living with virologically suppressed HIV may still be candidates for antiretroviral therapy (ART) switch to improve treatment satisfaction and quality of life. Topics covered include: Reasons to consider regimen optimization in setting of viral suppression Available switch regimens, including 2-drug regimens and long-acting ART Approaches to assess for resistance before starting long-acting cabotegravir plus rilpivirine DHHS recommendations on pr...
Nov 25, 2025•32 min•Ep. 480
